Search

Your search keyword '"Thomas Mandrup-Poulsen"' showing total 59 results

Search Constraints

Start Over You searched for: Author "Thomas Mandrup-Poulsen" Remove constraint Author: "Thomas Mandrup-Poulsen" Language english Remove constraint Language: english
59 results on '"Thomas Mandrup-Poulsen"'

Search Results

1. Tipping-point transition from transient to persistent inflammation in pancreatic islets

2. Proinflammatory cytokines suppress nonsense-mediated RNA decay to impair regulated transcript isoform processing in pancreatic β cells

4. Age-dependent transition from islet insulin hypersecretion to hyposecretion in mice with the long QT-syndrome loss-of-function mutation Kcnq1-A340V

5. Interleukin-6 receptor blockade or TNFα inhibition for reducing glycaemia in patients with RA and diabetes: post hoc analyses of three randomised, controlled trials

6. FK506-Binding Protein 2 Participates in Proinsulin Folding

7. Mitophagy protects β cells from inflammatory damage in diabetes

8. GPR183 Regulates Interferons, Autophagy, and Bacterial Growth During Mycobacterium tuberculosis Infection and Is Associated With TB Disease Severity

9. Combination of ferric ammonium citrate with cytokines involved in apoptosis and insulin secretion of human pancreatic beta cells related to diabetes in thalassemia

10. Defective Proinsulin Handling Modulates the MHC I Bound Peptidome and Activates the Inflammasome in β-Cells

11. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β.

12. The Lysine Demethylase KDM5B Regulates Islet Function and Glucose Homeostasis

13. MicroRNAs and histone deacetylase inhibition-mediated protection against inflammatory β-cell damage.

14. A Placebo-Controlled Study on the Effects of the Glucagon-Like Peptide-1 Mimetic, Exenatide, on Insulin Secretion, Body Composition and Adipokines in Obese, Client-Owned Cats.

15. JNK1 Deficient Insulin-Producing Cells Are Protected against Interleukin-1β-Induced Apoptosis Associated with Abrogated Myc Expression

16. Tissue Inhibitor Of Matrix Metalloproteinase-1 Is Required for High-Fat Diet-Induced Glucose Intolerance and Hepatic Steatosis in Mice.

17. JNK1 protects against glucolipotoxicity-mediated beta-cell apoptosis.

18. High glucose suppresses human islet insulin biosynthesis by inducing miR-133a leading to decreased polypyrimidine tract binding protein-expression.

19. In Vitro Inhibition of Insulin Release by Blood Mononuclear Cells from Insulin-Dependent Diabetic and Healthy Subjects: Synergistic Action of IL-1 and TNF

20. A randomised, double-blind, crossover study of the effect of the fluoroquinolone moxifloxacin on glucose levels and insulin sensitivity in young men and women

21. A Blunted GPR183/Oxysterol Axis during Dysglycemia Results in Delayed Recruitment of Macrophages to the Lung during Mycobacterium tuberculosis Infection

22. Divalent metal transporter 1 knock-down modulates il-1β mediated pancreatic beta-cell pro-apoptotic signaling pathways through the autophagic machinery

23. Proinflammatory Cytokines Perturb Mouse and Human Pancreatic Islet Circadian Rhythmicity and Induce Uncoordinated β-Cell Clock Gene Expression via Nitric Oxide, Lysine Deacetylases, and Immunoproteasomal Activity

24. Pancreatic β-cells respond to fuel pressure with an early metabolic switch

25. The Connexin 43 Regulator Rotigaptide Reduces Cytokine-Induced Cell Death in Human Islets

26. Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 94 Is Essential for Proinsulin Handling

27. Interleukin-37 treatment of mice with metabolic syndrome improves insulin sensitivity and reduces pro-inflammatory cytokine production in adipose tissue

28. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, low concentrations of interleukin 1 β

29. Enhancer of Zeste Homolog 2 (EZH2) Mediates Glucolipotoxicity-Induced Apoptosis in beta-Cells

30. The intermediate proteasome is constitutively expressed in pancreatic beta cells and upregulated by stimulatory, non-toxic concentrations of interleukin 1 β

31. Urinary nucleic acid oxidation product levels show differential associations with pharmacological treatment in patients with type 2 diabetes

32. No direct effect of SGLT2 activity on glucagon secretion

33. Limited benefit of haemoglobin glycation index as risk factor for cardiovascular disease in type 2 diabetes patients

34. The connexin 43 regulator Rotigaptide reduces cytokine-induced cell death in human islets

35. Iron Status and Gestational Diabetes—A Meta-Analysis

36. Acute administration of interleukin-6 does not increase secretion of glucagon-like peptide-1 in mice

38. A guiding map for inflammation

39. Proinflammatory Cytokines Activate the Intrinsic Apoptotic Pathway in β-Cells

40. Mixed-Meal Tolerance Test Versus Glucagon Stimulation Test for the Assessment of β-Cell Function in Therapeutic Trials in Type 1 Diabetes

41. A Systematic Comparison of Purification and Normalization Protocols for Quantitative MicroRNA Expressional Profiling in Insulin-Producing Cells

42. BMI is an important driver of β-cell loss in type 1 diabetes upon diagnosis in 10 to 18-year-old children

43. Helsinki alert of biodiversity and health

44. Altering β-cell number through stable alteration of miR-21 and miR-34a expression

45. Lysine deacetylase inhibition prevents diabetes by chromatin-independent immunoregulation and β-cell protection

46. The lysine deacetylase inhibitor givinostat inhibits β-cell IL-1β induced IL-1β transcription and processing

47. Proliferation of sorted human and rat beta cells

48. 40(th) EASD Annual Meeting of the European Association for the Study of Diabetes : Munich, Germany, 5-9 September 2004

49. Islet Protein Expression Changes during Diabetes Development in Islet Syngrafts in BB-DP Rats and During Rejection of BB-DP Islet Allografts

50. Interleukin-1beta induced changes in the protein expression of rat islets: a computerized database

Catalog

Books, media, physical & digital resources